{Reference Type}: Case Reports
{Title}: Thalidomide: An option for the pediatric patient with actinic prurigo.
{Author}: Watts-Santos A;Martinez-Rico JC;Gomez-Flores M;Ocampo-Candiani J;Alba-Rojas E;
{Journal}: Pediatr Dermatol
{Volume}: 37
{Issue}: 2
{Year}: Mar 2020
{Factor}: 1.997
{DOI}: 10.1111/pde.14086
{Abstract}: Actinic prurigo (AP) is an immune-mediated photodermatosis that usually starts in childhood and is predominant among American indigenous and mestizo communities. In adults with AP, thalidomide is the treatment of choice; however, there is little information on its use in pediatric patients. We report the case of a 10-year-old girl with AP treated successfully with thalidomide.